Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
about
A polycystin-centric view of cyst formation and disease: the polycystins revisitedRegulation of STATs by polycystin-1 and their role in polycystic kidney diseaseAutophagy and regulation of cilia function and assemblyMacrophages promote polycystic kidney disease progression.Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathwaysThe cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.The cell biology of polycystic kidney diseaseProtein kinase D-mediated phosphorylation of polycystin-2 (TRPP2) is essential for its effects on cell growth and calcium channel activity.Kidney: polycystic kidney disease.Filamin-a increases the stability and plasma membrane expression of polycystin-2.Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severityG-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease.Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.ERK-mediated suppression of cilia in cisplatin-induced tubular cell apoptosis and acute kidney injury.Primary cilia and kidney injury: current research status and future perspectivesAutocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney diseaseMolecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.Inflammation and Fibrosis in Polycystic Kidney Disease.Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.Phosphoinositide 3-Kinase-C2α Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation.Acute Kidney Injury in ADPKD Patients with Pneumonia.Environmental hit on a genetic basis in polycystic kidney disease.Acute kidney injury induces hallmarks of polycystic kidney disease.Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease.
P2860
Q26800974-AC1D7962-039F-4A89-99D3-5EBE3E0C6F06Q26852136-DE3D62CD-C9A9-4BA3-8EB9-CA2FDC412AE5Q26865107-7B2B78B4-5D46-4DA0-981C-8E31FDFEAED7Q33640257-A965F477-D150-4A09-A38E-1F0D0EB43378Q33682798-6530DE5C-590D-4A66-8EFB-0BB460C69274Q33974670-59698D64-D6EE-4C45-B67D-CB6C97C0B819Q34149966-89D1202C-1F53-49A1-9B40-E97D536A5931Q34313539-42040A0D-6848-4700-8905-620321CC2049Q34436755-DA51B5EA-C5FF-4B23-9AF2-3EFE8EB82186Q35362830-3C0AE727-1277-4857-9C56-3FA089C73D1DQ35969173-23D6BA8D-38AC-4C56-97B2-332165600C24Q36504457-85E5D55B-FF43-44A9-A176-BC2B33B9AA13Q36528128-318083FF-6467-4482-884E-020D5E754F0CQ37118337-5D01CD27-8381-4697-AB26-7C59DA7D90DFQ37234721-62E8B1D4-F865-4649-9DA9-5907824D01CBQ37305901-B39F330E-CD93-44E6-A26B-B79D40961379Q37882447-CE7AD49B-612B-4138-B955-C3C4A0EFFAB1Q38255110-B15F141C-97B3-4154-AF8D-14980BDAA281Q38837265-C19A349E-EC65-4337-8A5F-134228DD6568Q38919283-8D9B55E7-4734-4AD5-9AAB-CFA9A4BA9B29Q39693435-A1975BD0-ECC5-4D15-8EBB-9843BDF2E810Q42125410-7B69716A-D616-4F6C-BBB4-849B3BCE8CC3Q45807046-F1A0C8EB-A2C6-466A-9D17-3C0095E567AEQ51595824-99B71BEE-36DC-4D97-A8AF-1395107932B2Q53035502-47C216B7-253C-4F2A-912E-8716A6807B09
P2860
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@en
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@nl
type
label
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@en
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@nl
prefLabel
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@en
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@nl
P2093
P2860
P1476
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.
@en
P2093
Albert Chee Meng Ong
Frederick Wai Keung Tam
John Lionel Haylor
John Patrick McDaid
Sony Prasad
P2860
P304
P356
10.2353/AJPATH.2009.090227
P407
P577
2009-09-03T00:00:00Z